Status:
RECRUITING
Safety and Efficacy of Topical Cream for Post-inflammatory Hyperpigmentation Skin Among Malaysians
Lead Sponsor:
Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre
Conditions:
Healthy
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
This study was conducted to determine safety and efficacy of topically applied cream containing combination of niacinamide, arbutin, Scutellaria Baicalensis Root Extract, Centella Asiatica Extract and...
Eligibility Criteria
Inclusion
- Malaysia citizen
- Healthy adult, aged between 18 to 40 years old.
- Participants who have post-inflammatory hyperpigmentation on skin
Exclusion
- Participants with skin disorders such as skin infection or skin inflammation.
- Participants who have undergone any skin and cosmetic treatments such as dermal fillers, botox, laser, chemical peels within the last 3 months.
- Participant who is taking isotretinoin for the past 6 or 12 months and immunocompromised patients.
- Pregnant, breastfeeding women or planned for pregnancy during the study period.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2025
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT05986123
Start Date
November 1 2023
End Date
November 30 2025
Last Update
March 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre
Petaling Jaya, Selangor, Malaysia, 47810